Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML
Apply
BCL-XL Inhibition
Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step